Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Rastogi

Showing results (61-70 of 63) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 63 results.
RSC Advances|May 2, 2022
Tetrahydropyrazolopyridines as antifriction and antiwear agents: experimental and DFT calculationsKavita, Pratibha Verma, Dinesh K Verma, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
Zeniplatin in patients with advanced ovarian cancer, a phase II study with a third generation platinum complexP H Willemse, J A Gietema, N H Mulder, et al.
European Journal of Cancer (Oxford, England : 1990)|June 1, 1995
Long-term results of a multicentre randomised, comparative phase III trial of CHOP versus CNOP regimens in patients with intermediate- and high-grade non-Hodgkin's lymphomas. Novantrone International Study GroupW Bezwoda, R B Rastogi, A Erazo Valla, et al.
Pageof 7

Showing results (61-70 of 63) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 63 results.
RSC Advances|May 2, 2022
Tetrahydropyrazolopyridines as antifriction and antiwear agents: experimental and DFT calculationsKavita, Pratibha Verma, Dinesh K Verma, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
Zeniplatin in patients with advanced ovarian cancer, a phase II study with a third generation platinum complexP H Willemse, J A Gietema, N H Mulder, et al.
European Journal of Cancer (Oxford, England : 1990)|June 1, 1995
Long-term results of a multicentre randomised, comparative phase III trial of CHOP versus CNOP regimens in patients with intermediate- and high-grade non-Hodgkin's lymphomas. Novantrone International Study GroupW Bezwoda, R B Rastogi, A Erazo Valla, et al.
Pageof 7